– Expansion of Phase 1 CALiPSO-1 trial of CNTY-101 in autoimmune disease to include diffuse cutaneous systemic sclerosis and idiopathic inflammatory myopathy – – Overall response rate (ORR) of 83% ...
Italy's Eni has agreed that its recent Calypso-1 discovery off Cyprus could hold between 6 trillion and 8 trillion cubic feet of gas, but insisted more drilling is needed to gauge its precise size and ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Century Therapeutics, Inc. is conducting ...
Hosted on MSN
Century Therapeutics Reports Positive Q1 2025 Results and Advances in Cell Therapy Pipeline
PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) reported notable progress in Q1 2025, emphasizing advancements in its clinical and preclinical iPSC-derived cell therapy programs.
CALiPSO-1 will assess CNTY-101 in patients who have been exposed to two or more standard immunosuppressive therapies. The trial is on track to be initiated in the first half of 2024 with preliminary ...
Eni says it has confirmed the extension of a play akin to its Zohr gas discovery off Egypt after confirming it has made a "promising" find off Cyprus. The Italian major remained coy, however, on key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results